Treatment Patterns of Disease-Modifying Anti-Rheumatic Drugs by Serostatus Among Patients with Rheumatoid Arthritis

被引：0
|
作者：
Jin, Yinzhu [1 ]
Liu, Jun [1 ]
Desai, Rishi [1 ]
Kim, Seoyoung [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1761
引用
收藏
页码：3476 / 3479
页数：4
相关论文
共 50 条
  • [41] Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
    Ahmad Y. Abuhelwa
    Ashley M. Hopkins
    Michael J. Sorich
    Susanna Proudman
    David J. R. Foster
    Michael D. Wiese
    Scientific Reports, 10
  • [42] Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs
    Abuhelwa, Ahmad Y.
    Hopkins, Ashley M.
    Sorich, Michael J.
    Proudman, Susanna
    Foster, David J. R.
    Wiese, Michael D.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [43] Adverse drug reactions associated with the use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
    Enrique Machado-Alba, Jorge
    Felipe Ruiz, Andres
    Enrique Machado-Duque, Manuel
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2014, 36 (06): : 396 - 401
  • [44] Non-Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: An Italian Survey
    Bianchi, Gerolamo
    Carletto, Antonio
    Epis, Oscar M.
    Scioscia, Crescenzio
    Semeraro, Angelo
    Donati, Chiara
    Bazzichi, Laura
    Lapadula, Giovanni
    Sinigaglia, Luigi
    Lo Monaco, Andrea
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [45] Outcomes with Biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) in Older Patients Treated for Rheumatoid Arthritis
    Akter, Ripa
    Maksymowych, Walter P.
    Martin, M. Liam
    Hogan, David B.
    CANADIAN GERIATRICS JOURNAL, 2020, 23 (02) : 184 - 189
  • [46] Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients with Rheumatoid Arthritis?
    Ling-Chun Huang
    Yu-Han Chang
    Yuan-Han Yang
    Neurotherapeutics, 2019, 16 : 703 - 709
  • [47] Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients with Rheumatoid Arthritis?
    Huang, Ling-Chun
    Chang, Yu-Han
    Yang, Yuan-Han
    NEUROTHERAPEUTICS, 2019, 16 (03) : 703 - 709
  • [48] THE EFFECT OF BIOLOGICAL AND CONVENTIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS ON FATIGUE IN FIBROMYALGIC RHEUMATOID ARTHRITIS PATIENTS
    Hizmetli, S.
    Durmaz, Y.
    Kaptanoglu, E.
    Cengiz, A. K.
    Peksen, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 864 - 864
  • [49] Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis
    Garton, Mark
    McInnes, Iain B.
    Sattar, Naveed
    RHEUMATOLOGY, 2020, 59 (02) : 453 - 454
  • [50] Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis
    Kurata, Izumi
    Tsuboi, Hiroto
    Terasaki, Mayu
    Shimizu, Masaru
    Toko, Hirofumi
    Honda, Fumika
    Ohyama, Ayako
    Yagishita, Mizuki
    Osada, Atsumu
    Ebe, Hiroshi
    Kawaguchi, Hoshimi
    Takahashi, Hiroyuki
    Hagiwara, Shinya
    Asashima, Hiromitsu
    Kondo, Yuya
    Matsumoto, Isao
    Sumida, Takayuki
    INTERNAL MEDICINE, 2019, 58 (12) : 1703 - 1712
12345